These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study. Figueroa MS, Ruiz-Moreno JM, Gonzalez del Valle F, Govetto A, de la Vega C, Plascencia RN, Contreras I, Medina JL. Retina; 2015 Sep; 35(9):1836-43. PubMed ID: 25946689 [Abstract] [Full Text] [Related]
8. Posterior scleral reinforcement and vitrectomy for myopic foveoschisis in extreme myopia. Qi Y, Duan AL, You QS, Jonas JB, Wang N. Retina; 2015 Feb; 35(2):351-7. PubMed ID: 25111687 [Abstract] [Full Text] [Related]
14. Risk factors for development of full-thickness macular holes after pars plana vitrectomy for myopic foveoschisis. Gao X, Ikuno Y, Fujimoto S, Nishida K. Am J Ophthalmol; 2013 Jun; 155(6):1021-1027.e1. PubMed ID: 23522356 [Abstract] [Full Text] [Related]
15. Reoperation for persistent myopic foveoschisis after primary vitrectomy. Sayanagi K, Ikuno Y, Tano Y. Am J Ophthalmol; 2006 Feb; 141(2):414-7. PubMed ID: 16458717 [Abstract] [Full Text] [Related]
17. [Analysis of the therapeutic efficacy of pars plana vitrectomy without intraocular tamponade in the treatment of high myopic eyes with myopic foveoschisis and central foveal detachment]. Tang WY, Chen X, Zhang T, Huang X, Chang Q, Xu GZ. Zhonghua Yan Ke Za Zhi; 2024 Mar 11; 60(3):234-241. PubMed ID: 38462371 [Abstract] [Full Text] [Related]